SYNTHESIS OF 9-ARYL-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2Н,5Н)-DIONES
155
and 6 of the heterocycle (0.84–0.86, 1.03–1.05 ppm),
four doublets of protons at the С2, С7 and С4, С5 atoms
(1.96–2.40 ppm) with spin-spin coupling constant
16.5 Hz, and the spectra of compounds 1a–1c
contained multiplets of four protons at the С2 and С7
atoms (2.05–2.48 ppm), the С4 and С5 atoms (1.81–
2.25 ppm), С3 and С6 atoms (1.69–1.92 ppm). The
signals multiplicity was determined by the presence of
a chiral center in the position 9 of the molecules, making
the protons in positions 2, 4, 5, and 7 enantiotropic.
С2Н2, С7Н2), 1.87–1.96 m (4Н, С4Н2, С5Н2), 1.71–1.83
m (4Н, С3Н2, С6Н2), 4.90 s (1Н, С9Н), 7.20–7.92 m (4Н,
Ar), 9.54 s (1Н, NH). Found, %: С 67.45; Н 5.36; N 8.18.
С22Н14N2O4. Calculated, %: С 67.15; Н 5.53; N 7.98.
3,3,6,6-Tetramethyl-9-(4-methoxyphenyl)-
3,4,6,7,9,10-hexahydroacridine-1,8(2Н,5Н)-dione
(1d). Yield 2.95 g (78%), mp 273–275°С. IR spec-
trum, ν, cm–1: 1596 (С=C), 1644 (С=O), 3192 (NН).
1Н NMR spectrum, δ, ppm: 0.84 s and 1.052 s (12Н,
СН3), 1.96 d (2Н, С4Н2, J = 16.5 Hz), 2.11 d (2Н,
С5Н2, J = 16.5 Hz), 2.32 d (2Н, С2Н2, J = 16.5 Hz),
2.38 d (2Н, С7Н2, J = 16.5 Hz), 3.65 s (3Н, OCH3),
6.52–7.06 m (4Н, Ar), 8.36 s (1Н, NH). Found, %: С
75.96; Н 7.70; N 3.69. С24Н29NO3. Calculated, %: С
75.81; Н 7.89; N 3.85.
The spectral data showed that compounds 1a–1e
existed in the keto form with the proton localized at the
nitrogen atom.
Antimicrobial activity of compounds 1a–1e was
determined using a method of twofold serial dilution in
a liquid medium. Minimal suppressing concentrations
MSC (µg/mL) against the S. aureus АТСС 6538 and
E. coli ATCC 25922 strains [4] were determined. MSC
of the studied compounds was 1000 µg/mL, whereas
the MSC of a reference drug Dioxidine was 62.5–
1000 µg/mL against S. aureus АТСС 6538 and 3.9–
6.2 µg/mL against E. coli ATCC 25922. Hence, com-
pounds 1a–1e exhibited low antimicrobial activity.
3,3,6,6-Tetramethyl-9-(4-nitrophenyl)-3,4,6,7,9,10-
hexahydroacridine-1,8(2Н,5Н)-dione (1e). Yield
3.10 g (81%), mp >300°С. IR spectrum, ν, cm–1: 1596
(С=C), 1644 (С=O), 3192 (NН). 1Н NMR spectrum, δ,
ppm: 0.86 s and 1.042 s (12Н, СН3), 1.98 d (2Н, С4Н2,
J = 16.5 Hz), 2.08 d (2Н, С5Н2, J = 16.5 Hz), 2.29 d
(2Н, С2Н2, J = 16.5 Hz), 2.41 d (2Н, С7Н2, J = 16.5 Hz),
4.67 s (1Н, С9Н), 6.50–7.10 m (4Н, Ar), 8.41 s (1Н,
NH). Found, %: С 71.96; Н 6.83; N 3.65. С23Н26NO2Cl.
Calculated, %: С 71.72; Н 6.53; N 3.35.
1Н NMR spectra were recorded using a Bruker
DRX-500 instrument (500.13 MHz) in DMSO-d6 with
TMS as internal reference. IR spectra (KBr pellets)
were recorded using a Specord М-80 spectrophoto-
meter. Elemental analysis was performed using a Perkin
Elmer 2400 instrument. Melting points were determined
using a Melting Point M-565 instrument. The reaction
progress and the products purity were monitored by
means of TLC on Silufol UV-254 plates in a CHCl3–
AcOH (9 : 1) system developing with UV irradiation.
9-(4-Chlorophenyl)-3,4,6,7,9,10-hexahydroacridine-
1,8(2Н,5Н)-dione (1a). A mixture of 0.02 mol of 1,3-
cyclohexanedione, 0.01 mol of aromatic aldehyde, and
0.01 mol of ammonium acetate was kept during 10–
15 min at 150–160°С until gas evolution had ceased
and the reaction mixture became solid. After cooling,
the solid residue was treated with ethanol, filtered, and
recrystallized from ethanol. Yield 2.73 g (76%), mp
>300°С. IR spectrum, ν, cm–1: 1604 (С=С), 1644 (С=О),
1
3176 (NН). Н NMR spectrum, δ, ppm: 2.15–2.26 m
(4Н, С2Н2, С7Н2), 1.87–1.95 m (4Н, С4Н2, С5Н2), 1.75–
1.83 m (4Н, С3Н2, С6Н2), 4.82 s (1Н, С9Н), 6.92–7.36 m
(4Н, Ar), 9.36 s (1Н, NH). Found, %: С 69.62; Н 5.53; N
4.27. С22Н14NO2Cl. Calculated, %: С 69.52; Н 5.43; N 4.37.
ACKNOWLEDGMENTS
This work was financially supported by the Russian
Science Foundation (project no. 15-13-10029).
9-(4-Methoxyphenyl)-3,4,6,7,9,10-hexahydroacridine-
1,8(2Н,5Н)-dione (1b). Yield 2.77 g (78%), mp 273–
275°С. IR spectrum, ν, cm–1: 1612 (С=C), 1648 (С=O),
REFERENCES
1. Mashkovskii, M.D., Lekarstvennye sredstva (Drugs),
Moscow: RIA Novaya Volna, 2005.
2. Chebanov, V.A., Saraev, V.E., and Kobzar, K.M.,
Chem. Heterocycl. Compd., 2004, vol. 40, no. 4, p. 475.
doi 10.1023/B:COHC.0000033541.49115.a0
1
3176 (NН). Н NMR spectrum, δ, ppm: 2.15–2.26 m
(4Н, С2Н2, С7Н2), 1.83–1.91 m (4Н, С4Н2, С5Н2), 1.69–
1.78 m (4Н, С3Н2, С6Н2), 3.70 s (3Н, ОCH3), 4.87 s (1Н,
С9Н), 7.12–7.92 m (4Н, Ar), 9.56 s (1Н, NH). Found, %:
С 74.28; Н 6.55; N 4.33. С23Н17NO3. Calculated, %: С
74.58; Н 6.85; N 4.13.
3. Wang, G.W. and Miao, C.B., Green Chem., 2006, no. 8,
p. 1080. doi 10.1039/B604064K
4. Rukovodstvo po eksperimental’nomu (doklinicheskomu)
izucheniyu novykh farmakologicheskikh veshchestv
[Manual on Experimental (Preclinical) Study of New
Pharmacological Substances], Khabriev, R.U., Ed.,
Moscow: Meditsina, 2005.
9-(3-Nitrophenyl)-3,4,6,7,9,10-hexahydroacridine-
1,8(2Н,5Н)-dione (1c). Yield 2.97 g (80%), mp. >300°С.
IR spectrum, ν, cm–1: 1608 (С=C), 1640 (С=O), 3184
1
(NН). Н NMR spectrum, δ, ppm: 2.10–2.23 m (4Н,
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 87 No. 1 2017